A new trading day began on Friday, with Terns Pharmaceuticals Inc (NASDAQ: TERN) stock price up 8.22% from the previous day of trading, before settling in for the closing price of $27.13. TERN’s price has ranged from $1.87 to $29.51 over the past 52 weeks.
Annual sales at Healthcare sector company grew by 16.38% over the past five years. Meanwhile, its annual earnings per share averaged 2.44%. With a float of $75.71 million, this company’s outstanding shares have now reached $87.51 million.
Terns Pharmaceuticals Inc (TERN) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Terns Pharmaceuticals Inc is 15.96%, while institutional ownership is 81.68%. The most recent insider transaction that took place on Nov 04 ’25, was worth 441,360. In this transaction Director of this company sold 24,520 shares at a rate of $18.00, taking the stock ownership to the 0 shares. Before that another transaction happened on Nov 04 ’25, when Company’s Director proposed sale 24,520 for $14.03, making the entire transaction worth $344,016.
Terns Pharmaceuticals Inc (TERN) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.24 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.31 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 2.44% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -7.37% during the next five years compared to 16.38% growth over the previous five years of trading.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Trading Performance Indicators
Here are Terns Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 19.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.03, a number that is poised to hit -0.30 in the next quarter and is forecasted to reach -1.24 in one year’s time.
Technical Analysis of Terns Pharmaceuticals Inc (TERN)
Terns Pharmaceuticals Inc (NASDAQ: TERN) saw its 5-day average volume 3.81 million, a positive change from its year-to-date volume of 1.63 million. As of the previous 9 days, the stock’s Stochastic %D was 58.60%.
During the past 100 days, Terns Pharmaceuticals Inc’s (TERN) raw stochastic average was set at 96.44%, which indicates a significant increase from 88.32% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.98 in the past 14 days, which was higher than the 0.83 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $15.70, while its 200-day Moving Average is $7.28. Nevertheless, the first resistance level for the watch stands at $30.60 in the near term. At $31.84, the stock is likely to face the second major resistance level. The third major resistance level sits at $33.43. If the price goes on to break the first support level at $27.77, it is likely to go to the next support level at $26.18. The third support level lies at $24.94 if the price breaches the second support level.
Terns Pharmaceuticals Inc (NASDAQ: TERN) Key Stats
With a market capitalization of 2.64 billion, the company has a total of 90,080K Shares Outstanding. Currently, annual sales are 0 K while annual income is -88,850 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,640 K.
